![Huw Mottram](https://profiles-cardiff.imgix.net/attachments/1136?w=200&h=200&auto=format&crop=faces&fit=crop&q=90")
Mr Huw Mottram
Teams and roles for Huw Mottram
Core Technologies Hub Manager
Biosi Technical Support
Publication
2017
- Pope, S. J. A. et al. 2017. Anticancer, azonafide-inspired fluorescent ligands and their rhenium(I) complexes for cellular imaging. European Journal of Inorganic Chemistry 2017 (3), pp.759-766. (10.1002/ejic.201601271)
2015
- Gee, J. M. et al. 2015. A new cell panel to study oestrogen receptor loss in acquired endocrine resistant breast cancer. Cancer Research 75 (9) P3-05-19.
- Langdon-Jones, E. E. et al. 2015. Alkynyl-naphthalimide fluorophores: gold coordination chemistry and cellular imaging applications. Inorganic Chemistry 54 (13), pp.6606-6615. 150618152106000. (10.1021/acs.inorgchem.5b00954)
2014
- Gee, J. M. W. et al. 2014. Increased Ret signalling and impact of vandetanib in acquired tamoxifen resistant breast cancer. Cancer Research 74 (19) 738. (10.1158/1538-7445.AM2014-738)
- Jordan, N. J. et al. 2014. Impact of dual mTORC1/2 mTOR kinase inhibitor AZD8055 on acquired endocrine resistance in breast cancer in vitro. Breast Cancer Research 16 (1), pp.-. R12. (10.1186/bcr3604)
2012
- Balasingham, R. et al. 2012. Gold(I) complexes derived from alkynyloxy-substituted anthraquinones: Syntheses, luminescence, preliminary cytotoxicity, and cell imaging studies. Organometallics 31 (16), pp.5835-5843. (10.1021/om300475y)
- Mullice, L. A. et al. 2012. Gold(I) complexes incorporating emissive mercapto-pteridine ligands: Syntheses, X-ray structure, luminescence and preliminary cytotoxic evaluation. European Journal of Inorganic Chemistry 2012 (18), pp.3054-3060. (10.1002/ejic.201200147)
2010
- Mehellou, Y. et al. 2010. Phosphoramidates of 2′-β-d-arabinouridine (AraU) as phosphate prodrugs; design, synthesis, in vitro activity and metabolism. Bioorganic & Medicinal Chemistry 18 (7), pp.2439-2446. (10.1016/j.bmc.2010.02.059)
Articles
- Balasingham, R. et al. 2012. Gold(I) complexes derived from alkynyloxy-substituted anthraquinones: Syntheses, luminescence, preliminary cytotoxicity, and cell imaging studies. Organometallics 31 (16), pp.5835-5843. (10.1021/om300475y)
- Gee, J. M. et al. 2015. A new cell panel to study oestrogen receptor loss in acquired endocrine resistant breast cancer. Cancer Research 75 (9) P3-05-19.
- Gee, J. M. W. et al. 2014. Increased Ret signalling and impact of vandetanib in acquired tamoxifen resistant breast cancer. Cancer Research 74 (19) 738. (10.1158/1538-7445.AM2014-738)
- Jordan, N. J. et al. 2014. Impact of dual mTORC1/2 mTOR kinase inhibitor AZD8055 on acquired endocrine resistance in breast cancer in vitro. Breast Cancer Research 16 (1), pp.-. R12. (10.1186/bcr3604)
- Langdon-Jones, E. E. et al. 2015. Alkynyl-naphthalimide fluorophores: gold coordination chemistry and cellular imaging applications. Inorganic Chemistry 54 (13), pp.6606-6615. 150618152106000. (10.1021/acs.inorgchem.5b00954)
- Mehellou, Y. et al. 2010. Phosphoramidates of 2′-β-d-arabinouridine (AraU) as phosphate prodrugs; design, synthesis, in vitro activity and metabolism. Bioorganic & Medicinal Chemistry 18 (7), pp.2439-2446. (10.1016/j.bmc.2010.02.059)
- Mullice, L. A. et al. 2012. Gold(I) complexes incorporating emissive mercapto-pteridine ligands: Syntheses, X-ray structure, luminescence and preliminary cytotoxic evaluation. European Journal of Inorganic Chemistry 2012 (18), pp.3054-3060. (10.1002/ejic.201200147)
- Pope, S. J. A. et al. 2017. Anticancer, azonafide-inspired fluorescent ligands and their rhenium(I) complexes for cellular imaging. European Journal of Inorganic Chemistry 2017 (3), pp.759-766. (10.1002/ejic.201601271)